Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Amvisc

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Purpose: To quantify the hydroxyl radical scavenging activity of a new ophthalmic viscosurgical device (OVD) based on sodium… Expand
Is this relevant?
2004
2004
Purpose: To compare the protective effect of Healon®5 (sodium hyaluronate 2.3%) and Amvisc Plus® (sodium hyaluronate 1.6… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2000
2000
ZusammenfassungFragestellung: In einer prospektiven, randomisierten Studie soll überprüft werden, ob verschiedene Viskoelastika… Expand
Is this relevant?
1998
1998
Purpose: To compare the residual adherence of viscoelastics to the corneal endothelium following phacoemulsification in an in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
Two viscoelastic agents, Healon and Amvisc, both hyaluronic acids, were evaluated in two prospective, randomized and masked… Expand
Is this relevant?
1993
1993
ABSTRACT A prospective, randomized, observer‐marked study was conducted to compare corneal endothelial and intraocular pressure… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1987
1987
ABSTRACT A standardized investigation to compare the biophysical characteristics of two sodium hyaluronate products, AMVISC® and… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?
1985
1985
  • J. Alpar
  • Annals of ophthalmology
  • 1985
  • Corpus ID: 24471819
Twenty-two patients were randomly assigned to either Healon or Amvisc treatment during extracapsular cataract extraction and… Expand
Is this relevant?
1983
1983
Amvisc, a purified fraction of sodium hyaluronate, was evaluated and compared with Healon in cataract extraction and primary… Expand
Is this relevant?